Skip to main content

PGDx's LungSelect

Personal Genome Diagnostics has launched LungSelect, a next-generation sequencing assay that detects a panel of the most common, clinically actionable genetic alterations — including somatic sequence mutations and translocations — in the plasma of non-small cell lung cancer patients. 

The liquid biopsy test is able to detect sequence mutations and translocations at frequencies as low as 0.02 percent and 0.1 percent respectively, with sensitivity greater than 90 percent. The mutations covered are associated with sensitivity or resistance to approved therapies, and could also guide patients to clinical trials of experimental drugs.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.